Regulation of the Rat Liver Sodium-dependent Bile Acid Cotransporter Gene by Prolactin. Mediation of Transcriptional Activation by Stat5
Overview
Affiliations
The intracellular mechanism(s) underlying the upregulation of the hepatic Na+/taurocholate cotransporting polypeptide (ntcp) by prolactin (PRL) are unknown. In this report, we demonstrate a time-dependent increase in nuclear translocation of phosphorylated liver Stat5 (a member of the ignal ransducers and ctivators of ranscription family) that correlated with suckling-induced increases in serum PRL levels. In electrophoretic mobility gel shift assays, nuclear Stat5 exhibited specific DNA-binding ability towards IFN-gamma-activated sequence (GAS)-like elements (GLEs; 5'TTC/A-PyNPu-G/TAA-3') located in the -937 to -904 bp region of the ntcp promoter. Transient cotransfections in HepG2 cells revealed that PRL inducibility (2.5-3-fold) required coexpression of the long form of the PRL receptor (PRLRL) and Stat5. Deletion analysis mapped the PRLinducible region to -1237 to -758 bp of the ntcp promoter. Linking this 0.5-kb region to a heterologous thymidine kinase (tk) promoter, or linking multimerized ntcp GLEs either upstream of the ntcp minimal promoter (-158 to +47 bp) or the heterologous promoter conferred dose-dependent PRL responsiveness. The short form of the PRL receptor failed to transactivate ntcp GLEs. These results indicate that PRL acts via the PRLRL to facilitate Stat5 binding to ntcp-GLEs and to transcriptionally regulate ntcp.
The Culprit Behind HBV-Infected Hepatocytes: NTCP.
Li S, Hao L, Deng J, Zhang J, Yu F, Ye F Drug Des Devel Ther. 2024; 18:4839-4858.
PMID: 39494152 PMC: 11529284. DOI: 10.2147/DDDT.S480151.
Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment.
Li Y, Zhou J, Li T Front Mol Biosci. 2022; 9:879817.
PMID: 35495620 PMC: 9039015. DOI: 10.3389/fmolb.2022.879817.
Bu P, Le Y, Zhang Y, Zhang Y, Cheng X J Biol Chem. 2017; 292(11):4602-4613.
PMID: 28154180 PMC: 5377776. DOI: 10.1074/jbc.M116.757567.
Clinical application of transcriptional activators of bile salt transporters.
Baghdasaryan A, Chiba P, Trauner M Mol Aspects Med. 2013; 37:57-76.
PMID: 24333169 PMC: 4045202. DOI: 10.1016/j.mam.2013.12.001.
Boyer J Compr Physiol. 2013; 3(3):1035-78.
PMID: 23897680 PMC: 4091928. DOI: 10.1002/cphy.c120027.